Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SUNNYVALE, Calif., Aug. 6, 2013 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (OTCQB:AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis, today announced that its President and CEO Gerald Commissiong posted a mid-year President’s Letter to shareholders.
Help employers find you! Check out all the jobs and post your resume.
